Under inert atmosphere the flask is charged with methanol (MeOH) (50 mL) (Note 1), NaOH (20 mg, 0.5 mmol, 0.02 equiv) (Note 2) and then stirred vigorously for 10 min to complete dissolution of NaOH. The clear solution is cooled to 0 °C with an ice/water bath and to this is added Dglucuronolactone 1 (5.0 g, 28 mmol, 1.0 equiv) portion-wise (Note 3) over 25 min (Note 4). The solution is stirred for an additional 30 min, while maintaining the internal temperature at 0 °C. Upon complete dissolution of 1, the reaction solution is transferred to a one-necked 250-mL roundbottomed flask and the solvent removed by rotary evaporation (30 °C, 20 mmHg) (Note 5) to yield a pale yellow foam which is dried under vacuum (5 mmHg) for 2 h to remove the majority of residual MeOH ( Figure 2 ).
Figure 2. Pale yellow foam after removal of methanol
The flask (Note 6) containing the foam is charged with a 2-cm Teflon coated magnetic stirrer bar, acetic anhydride (54 g, 50 mL, 530 mmol, 19 equiv) and anhydrous NaOAc (9.5 g, 116 mmol, 4.1 equiv) (Note 7). A reflux condenser is attached, the reaction placed under nitrogen and the mixture heated (Note 8) to 90 °C for 1.5 h (Note 9). The light-brown suspension ( Figure 3 ) is then allowed to cool. The solution is no longer stirred and is left standing overnight.
Figure 3. Light brown suspension
The resulting precipitate is diluted with EtOAc (100 mL) and any solids broken up carefully with a spatula. This enables stirring of the suspension, which is continued vigorously for 5 min. The suspension is then filtered through a 100-mL medium porosity sintered glass funnel into a 0.5 L flask, washing the solids with an additional portion of EtOAc (100 mL). This filtrate is retained. Sodium bicarbonate (NaHCO 3 ) (90 g, 1.1 mol, 38 equiv) is weighed into a 1.0 L beaker on a stirrer plate and distilled water (250 mL) added. A 4-cm Teflon coated stirrer bar is added and stirring commenced to dissolve the majority of the NaHCO 3 . The reaction filtrate is added slowly to this stirred solution (Note 10) and stirring is continued for >30 min, or until all effervescence had ceased. The solution is then transferred to a 1.0 L separating funnel and the organic/aqueous layers separated. The aqueous phase is extracted once with EtOAc (50 mL) and the organics combined, washed with H 2 O (50 mL), dried over MgSO 4 (10.0 g) for 10 min, and filtered through a sintered glass funnel into a flask. The solvent is removed on a rotary evaporator (40 °C, 20 mmHg) to reveal a sticky, brown oil mixed with solids. This residue is dissolved in hot (70 °C) EtOH (50 mL) and allowed to cool, which induces crystallisation of 2. The solids are collected by vacuum filtration (Note 11) and dried under vacuum for 2 h (5 mmHg) furnishing 3.40 g (32%) of 2 as a light tan solid (Figure 4 ) (Notes 12 and 13). 6. As necessary and depending on the heating setup in use, the flask can be fitted with a Y-shaped adapter for a flexible thermocouple or a 2-necked flask used. 7. Acetic anhydride (ReagentPlus, ≥99%) and anhydrous NaOAc (ReagentPlus, ≥99%) were both obtained from Sigma Aldrich and used as received. 8. The pale yellow foam is quite sticky and may not immediately dissolve upon addition of the acetic anhydride and NaOAc. Heating from ambient temperature up to 90 °C is required to achieve this. As the solvent warms, the reagents will dissolve and a pale brown suspension results. The mixture was heated using a Drysyn™ heating block and temperature thermocouple. 9. If lower heating temperature of 50 °C is applied for 4 h and then the solution is allowed to cool to room temperature overnight, the reaction delivers an improved yield of 2 (4. 
Working with Hazardous Chemicals
The procedures in Organic Syntheses are intended for use only by persons with proper training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices In some articles in Organic Syntheses, chemical-specific hazards are highlighted in red "Caution Notes" within a procedure. It is important to recognize that the absence of a caution note does not imply that no significant hazards are associated with the chemicals involved in that procedure. Prior to performing a reaction, a thorough risk assessment should be carried out that includes a review of the potential hazards associated with each chemical and experimental operation on the scale that is planned for the procedure. Guidelines for carrying out a risk assessment and for analyzing the hazards associated with chemicals can be found in Chapter 4 of Prudent Practices.
The procedures described in Organic Syntheses are provided as published and are conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein.
Discussion
The synthesis of methyl 1,2,3,4-tetra-O-acetyl--D-glucopyranuronate 2 described builds on an original report by Bollenback et al. 2 In their article the authors prepare 2 using acid (periodic acid) or base (pyridine) catalyzed acetylation of the intermediate pyranouronate, obtained from methanolysis of 1. While this is a useful procedure on large scale (the original scale was >2.3 mol, 400 g of 1) we did not find it reliably reproducible on small to medium scales (often producing brown tars needing multiple repetitive chromatographic steps to isolate low % yields of 2), and we also sought to eliminate the use of periodic acid and/or pyridine. The use of NaOAc in acetic anhydride proved a convenient alternative for the acetylation step and the process could be reliably scaled to 10 g of 1. This method further provides an economic alternative to 2 derived from the commercially available, but more expensive D-glucuronic acid. 3 D-Glucuronate 2 is a commonly required uronate building block (Scheme 2). For example, it has been used to access non-readily available LIdoA units for the construction of complex heparin-related disaccharides, 4 via an intermediate C5-bromide (Scheme 2, A). It has also seen utility for access to and characterization of the important glucuronide-containing metabolite 5 (Scheme 2, C). 5 Importantly, 2 also serves as a vital precursor for the formation of alternative C-1 anomeric derivatives 4 (complicit to wider glycosylation applications and methodologies) including trichloroacetimidates, 5 hemi-acetals, 6 and glycosyl bromides 7 (Scheme 2, B). 
